Exploring small non-coding RNAs as blood-based biomarkers to predict Alzheimer's disease

Laia Gutierrez-Tordera,Christopher Papandreou,Nil Novau-Ferré,Pablo García-González,Melina Rojas,Marta Marquié,Luis A. Chapado,Christos Papagiannopoulos,Noèlia Fernàndez-Castillo,Sergi Valero,Jaume Folch,Miren Ettcheto,Antoni Camins,Mercè Boada,Agustín Ruiz,Mònica Bulló

DOI: https://doi.org/10.1186/s13578-023-01190-5

2024-01-17

Cell & Bioscience

Abstract:Alzheimer's disease (AD) diagnosis relies on clinical symptoms complemented with biological biomarkers, the Amyloid Tau Neurodegeneration (ATN) framework. Small non-coding RNA (sncRNA) in the blood have emerged as potential predictors of AD. We identified sncRNA signatures specific to ATN and AD, and evaluated both their contribution to improving AD conversion prediction beyond ATN alone.

biochemistry & molecular biology